Skip to main content

XNCR

Stock
Health Care
Biotechnology

Performance overview

XNCR Price
Price Chart

Forward-looking statistics

Beta
1.37
Risk
50.13%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

Company info

SectorHealth Care
IndustryBiotechnology
Employees290
Market cap$1.3B

Fundamentals

Enterprise value$312.0M
Revenue$127.2M
Revenue per employee—
Profit margin-163.17%
Debt to equity34.73

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$3.04
Dividend per share—
Revenue per share$1.87
Avg trading volume (30 day)$7M
Avg trading volume (10 day)$7M
Put-call ratio—

Macro factor sensitivity

Growth+2.6
Credit+5.2
Liquidity+0.1
Inflation-1.6
Commodities-0.2
Interest Rates-1.2

Valuation

Dividend yield0.00%
PEG Ratio-2.38
Price to sales4.58
P/E Ratio-2.38
Enterprise Value to Revenue2.45
Price to book0.91

Upcoming events

Next earnings dayMay 8, 2025
Next dividend day—
Ex. dividend day—

News

Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates

Xencor (XNCR) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $1.11 per share a year ago.

Zacks Investment Research (May 7, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free